       Document 0263
 DOCN  M9630263
 TI    Anti-HSV-1 herpes vaccination by LUPIDON H: preliminary results.
 DT    9603
 AU    De Maria A; Tundo P; Romano A; Grima P; Department of Infectious
       Diseases, S. Caterina Novella Hospital,; Galatina (Lecce), Italy.
 SO    Adv Exp Med Biol. 1995;371B:1599-600. Unique Identifier : AIDSLINE
       MED/96001802
 DE    Acyclovir/THERAPEUTIC USE  Adolescence  Adult  Child  Combined Modality
       Therapy  CD4 Lymphocyte Count  Female  Herpes Simplex/DRUG
       THERAPY/IMMUNOLOGY/*THERAPY  Herpesvirus 1, Human/*IMMUNOLOGY  Human
       Immunity, Cellular  Keratitis, Herpetic/DRUG THERAPY/IMMUNOLOGY/THERAPY
       Male  Middle Age  Recurrence  Stomatitis, Herpetic/DRUG
       THERAPY/IMMUNOLOGY/THERAPY  Vaccines, Inactivated/ADMINISTRATION &
       DOSAGE/THERAPEUTIC USE  Viral Vaccines/ADMINISTRATION &
       DOSAGE/*THERAPEUTIC USE  CLINICAL TRIAL  CONTROLLED CLINICAL TRIAL
       JOURNAL ARTICLE

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).

